Eligibility criteria
Condition
Overactive Urinary Bladder
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
Patients with increased urinary frequency and/or imperative urgency and/or urge
incontinence, as can occur in patients with overactive bladder syndrome, for whom Toviaz
was prescribed for treatment of the symptoms.
Patients will complete the OABv8 questionnaire and will need to meet a minimum score in
order to be eligible for the study.
Exclusion criteria
Show details
Patients who meet the contraindications in the Toviaz prescribing information (active
ingredient fesoterodine) will be excluded.